Inspire Medical Systems Inc - Asset Resilience Ratio

Latest as of March 2026: 20.29%

Inspire Medical Systems Inc (INSP) has an Asset Resilience Ratio of 20.29% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$184.90 Million
Cash + Short-term Investments

Total Assets

$911.38 Million
All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Inspire Medical Systems Inc's Asset Resilience Ratio has changed over time. Check Inspire Medical Systems Inc (INSP) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Inspire Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Inspire Medical Systems Inc (INSP) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $184.90 Million 20.29%
Total Liquid Assets $184.90 Million 20.29%

Asset Resilience Insights

  • Good Liquidity Position: Inspire Medical Systems Inc maintains a healthy 20.29% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Inspire Medical Systems Inc Industry Peers by Asset Resilience Ratio

Compare Inspire Medical Systems Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
Medical Devices 49.23%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Vitrolife AB
ST:VITR
Medical Devices 7.27%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Imricor Medical Systems Inc
AU:IMR
Medical Devices 46.50%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Inspire Medical Systems Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Inspire Medical Systems Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 22.42% $203.46 Million $907.32 Million -14.12pp
2024-12-31 36.54% $295.40 Million $808.38 Million -4.07pp
2023-12-31 40.61% $274.84 Million $676.81 Million +38.87pp
2022-12-31 1.74% $9.82 Million $564.88 Million --
2021-12-31 0.00% $0.00 $295.08 Million --
2020-12-31 15.59% $43.84 Million $281.19 Million -54.26pp
2019-12-31 69.85% $126.61 Million $181.25 Million +24.41pp
2018-12-31 45.44% $90.92 Million $200.08 Million +16.80pp
2017-12-31 28.65% $7.19 Million $25.09 Million --
2016-12-31 0.00% $0.00 $13.12 Million --
pp = percentage points

About Inspire Medical Systems Inc

NYSE:INSP USA Medical Devices
Market Cap
$1.73 Billion
Market Cap Rank
#8059 Global
#2360 in USA
Share Price
$60.09
Change (1 day)
-6.31%
52-Week Range
$40.05 - $143.99
All Time High
$326.08
About

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more